Polaryx Therapeutics, Inc. PLYX 深 滬
等待開盤 03-26 09:30:00 美东时间
6.28
-0.160
-2.48%
華盛通- 最 高6.90
- 今 開6.23
- 成交量 23.29万股
- 最 低 6.23
- 昨 收 6.44
- 總市值 2.97亿
- 52周最高 48.91
- 市盈率 靜 --
- 換手率 0.49%
- 52周最低 2.201
- 委 比 66.67%
- 總股本 4734.33万
- 歷史最高 48.91
- 量 比 0.30
- 振 幅 10.40%
- 歷史最低 2.201
- 每 手 1
- 風險率 9.15%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Polaryx Therapeutics Says FDA Grants Fast Track Designation To PLX-200 For Treatment Of Late-Infantile Neuronal Ceroid Lipofuscinosis
Regulatory milestone supports advancement of the SOTERIA Phase 2 basket trial evaluating PLX‑200 across multiple lysosomal storage disorders PARAMUS, NJ, March 17, 2026 (GLOBE NEWSWIRE) -- Polaryx Therapeutics, Inc.
03-17 20:33
美股牛股 | VYGR飙升21%，Q4亏损收窄及销售额超预期；Figure大涨超20%
VYGR飙升21%，Q4亏损收窄及销售额超预期；Figure大涨超20%，进军汽车贷款市场获华尔街唱多；Stagwell涨逾17%，引入AppLovin先进的移动广告平台>>
03-11 16:04
美股大行评级 | 下调居多！多邻国、Elastic、Flutter、欧特克、Zscaler等遭多家机构下调目标价
今日重点评级关注：巴克莱：维持C4 Therapeutics"超配"评级，目标价从5美元升至7美元；富国银行：维持Agilon Health"超配"评级，目标价从1美元升至1.5美元
03-02 14:08
Maxim Group Initiates Coverage On Polaryx Therapeutics with Buy Rating, Announces Price Target of $10
Maxim Group analyst Jason McCarthy initiates coverage on Polaryx Therapeutics (NASDAQ:PLYX) with a Buy rating and announces Price Target of $10.
02-28 05:28
What's Going On With Polaryx Therapeutics Stock Wednesday?
Polaryx Therapeutics Inc. (NASDAQ: PLYX) stock fell after a surge due to a major clinical development announcement.
02-18 23:19
Dow Gains 100 Points; Analog Devices Posts Upbeat Q1 Earnings
U.S. stocks traded higher this morning, with the Dow Jones index gaining around...
02-18 22:48
美股牛股 | Polaryx飙升逾64%，药物临床实验推进方面取得显著进展；麦斯莫医疗、以星综合航运均获高额溢价收购
Polaryx飙升逾64%，药物临床实验推进方面取得显著进展；麦斯莫医疗、以星综合航运均获高额溢价收购，隔夜分别大涨34%，25%>>
02-18 18:30
Small Cap Polaryx Picks Research Partner, Stock Surges on Phase 2 Trial Plans
Polaryx Therapeutics (NASDAQ: PLYX) shares rise on selecting research organization for SOTERIA trial to evaluate lead candidate for lysosomal storage disorders.
02-17 23:26
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers American Well (NYSE:AMWL) stock moved upwards by 31.2% to $5.68 during...
02-14 01:05
Polaryx Therapeutics Highlights Late-Breaking Presentation Of New Data For PLX-200, Investigational Therapy For Treatment Of Krabbe Disease At 22nd Annual WORLDSymposium
Polaryx Therapeutics (NASDAQ:PLYX), a clinical-stage biotechnology company developing novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders ("LSDs"), announced that the late-breaking
02-10 21:47
